QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)
Clinical trial NCT01782326 · COMPLETED
Trial details
- NCT number
- NCT01782326
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2015-09-01
- Enrollment
- 3362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.